Element Biosciences vs EyePoint Pharmaceuticals

Element Biosciences vs EyePoint Pharmaceuticals, compared side by side on 15 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Element Biosciences is on 53/100 and EyePoint Pharmaceuticals on 36/100.

Element Biosciences logo
Element BiosciencesRevolutionizing genomic analysis with innovative sequencing technology.
Try Element Biosciences
EyePoint Pharmaceuticals logo
EyePoint PharmaceuticalsOphthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.
Try EyePoint Pharmaceuticals

Where each one leads

Element Biosciences

  • our overall score: 53/100 against 36/100
  • domain rating: 66/100 against 43/100

EyePoint Pharmaceuticals

  • agent readiness: 50/100 against 34/100
  • funding raised: $436M against $175M

At a glance

MeasureElement BiosciencesEyePoint Pharmaceuticals
What it isRevolutionizing genomic analysis with innovative sequencing technology.Ophthalmology-focused biopharmaceutical company developing sustained-release drug delivery systems for serious eye diseases.
CategoryBiotechnology, Genomics, Life Sciences, Healthcare TechnologyBiotechnology, Biopharmaceuticals, Specialty Pharmaceuticals, Ophthalmology
Sells toBusiness modelB2BB2B
OfferingHardwareSoftware | hardware | services | marketplace | platform
Founded20171987
HeadquartersSan Diego, USAWatertown, United States
StatusActiveInactive

Size, funding and growth

MeasureElement BiosciencesEyePoint Pharmaceuticals
Total funding$175M$436M
Latest roundSeries EPublic Offering
Valuation$1.1BNot published

StartupHub scores

Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.

MeasureElement BiosciencesEyePoint Pharmaceuticals
StartupHub scoreOur 0-100 rating53/10036/100
Traction40/10040/100
TeamNot published30/100
Search visibility2/10013/100
Quality78/10040/100
Agent readinessHow well an AI agent can read and act on the siteF (34/100)D (50/100)
Domain ratingLink authority, 0-10066/10043/100

Technology

Detected on each public site, so it reflects the marketing stack as well as the product.

MeasureElement BiosciencesEyePoint Pharmaceuticals
HostingNot detectedGoogle Cloud
CDNCloudflareNot detected
FrameworksBootstrapNot detected
AnalyticsGoogle Analytics 4, Google Tag ManagerNot detected
Support stackHubSpotNot detected

What users say

MeasureElement BiosciencesEyePoint Pharmaceuticals
Reddit sentimentThreads we track1 positive, 0 negative across 3 threadsNot published
Element Biosciences
“The cost of sequencing human genome has fallen from $100M to under $100 in approximately 25 years. Element Biosciences reportedly hit the $100 genome milestone (Feb 2026).”
r/singularity

Element Biosciences vs EyePoint Pharmaceuticals: common questions

Which is better, Element Biosciences or EyePoint Pharmaceuticals?

On our 0-100 score Element Biosciences rates higher (53/100 against 36/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 15 data points above: read the rows that match what you are buying for.

How do Element Biosciences and EyePoint Pharmaceuticals compare on the numbers?

Element Biosciences leads on our overall score (53/100 against 36/100), domain rating (66/100 against 43/100). EyePoint Pharmaceuticals leads on agent readiness (50/100 against 34/100), funding raised ($436M against $175M).

What do real users say about Element Biosciences and EyePoint Pharmaceuticals?

Element Biosciences: 1 positive and 0 negative mentions across 3 Reddit threads we track, mostly in r/singularity.

Read the full Element Biosciences review and pricing or the EyePoint Pharmaceuticals review and pricing. You can also browse other Element Biosciences alternatives we track.